Liver health: NAFLD and NASH Non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), represent a growing health concern globally
The window of highest oral-drug-absorption risk is comparable for both agents
It raises interesting questions around whether future strategies could further optimize outcomes through combination approaches or more targeted pathway modulation
The perception of "ruined metabolism" often stems from the challenge of maintaining weight loss after discontinuation, which reflects the complex biology of weight regulation rather than drug-induced harm
Administration of Live Vaccines: Due to immunosuppression, patients taking prednisone should not receive live vaccines
Since they hit the market, both Ozempic and Wegovy have been in high demand, both for on-label and off-label use